Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID

類似資料

• Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice
  著者:: Carbonaro-Sarracino, Denise A., 等
  出版事項: (2019)
• Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients
  著者:: Cooper, Aaron R., 等
  出版事項: (2017)
• Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction
  著者:: Carbonaro, Denise A., 等
  出版事項: (2012)
• Busulfan Pharmacokinetics in ADA SCID Gene Therapy
  著者:: Bradford, Kathryn L., 等
  出版事項: (2020)
• Effects of Vector Backbone and Pseudotype on Lentiviral Vector-mediated Gene Transfer: Studies in Infant ADA-Deficient Mice and Rhesus Monkeys
  著者:: Carbonaro Sarracino, Denise, 等
  出版事項: (2014)